Insmed
(NASDAQ) INSM
Insmed Financials at a Glance
Market Cap
$24.19B
Revenue (TTM)
$819.56M
Net Income (TTM)
-$1.18B
EPS (TTM)
-$5.74
P/E Ratio
-19.43
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$111.60
Volume
145,991
Open
$107.79
Price
$111.60
Volume
145,991
Open
$107.79
Previous Close
$111.60
Daily Range
$107.19 - $111.74
52-Week Range
$90.39 - $212.75
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$111.60
Volume
145,991
Open
$107.79
Previous Close
$111.60
Daily Range
$107.19 - $111.74
52-Week Range
$90.39 - $212.75
Estimated Earnings Date
Aug 6, 2026
INSM News
INSM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Insmed
Industry
Biotechnology
Sector
Health CareEmployees
1,664
CEO
Will Lewis, MBA
Website
www.insmed.comHeadquarters
Bridgewater, NJ 08807, US
INSM Financials
Key Financial Metrics (TTM)
Gross Margin
81.56%
Operating Margin
-137.74%
Net Income Margin
-144.44%
Return on Equity
-130.11%
Return on Capital
-78.08%
Return on Assets
-57.02%
Earnings Yield
-5.15%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$24.19B
Shares Outstanding
216.75M
Volume
145.99K
Avg. Volume
3.73M
Financials (TTM)
Gross Profit
$668.40M
Operating Income
-$1.13B
EBITDA
-$1.08B
Operating Cash Flow
-$895.66M
Capital Expenditure
-$55.97M
Free Cash Flow
-$951.64M
Cash & ST Invst.
$1.22B
Total Debt
$748.44M
Insmed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$305.96M
+229.6%
Gross Profit
$256.46M
+258.5%
Gross Margin
83.82%
N/A
Market Cap
$24.19B
N/A
Market Cap/Employee
$19.03M
N/A
Employees
1,271
N/A
Net Income
-$163.56M
+36.3%
EBITDA
-$136.32M
+41.4%
Quarterly Fundamentals
Total Cash
$1.22B
+2.0%
Total Debt
$748.44M
-42.8%
Accounts Receivable
$178.56M
+274.0%
Inventory
$132.91M
+32.0%
Long Term Debt
$734.01M
-43.5%
Short Term Debt
$14.43M
+40.5%
Return on Assets
-57.02%
N/A
Return on Invested Capital
-65.83%
N/A
Free Cash Flow
-$226.22M
+16.9%
Operating Cash Flow
-$222.74M
+15.0%